Oliver Metzger ...
  • Stephan Wulf

BioNTech SE : Strong Q4 2022 figures – 2023 guidance disappointing

>FY22 Q4 figures topped beat our expectations and those of the market - Q4 revenues was € 4.278m, beating our estimate of € 3,850m and the consensus forecast of € 3,950m. As a result of the development of the coronavirus pandemic BioNTech’s top line declined y-o-y by 23%. EBIT was at € 3.293m vs our estimates of € 2,743m and the consensus forecast of € 2,817m. The EBIT margin declined y-o-y by nearly 800bp to 77%. BioNTech is guiding for 2023 Covid-19 vac...
BioNTech SE

Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Oliver Metzger

Stephan Wulf

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch